This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Qinglin Wang - Innovator in Pharmaceutical Chemistry
Introduction
Qinglin Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on addressing BTK-related diseases through novel therapeutic agents.
Latest Patents
Qinglin Wang holds a patent for a furo[3,4-b]pyrrole-containing BTK inhibitor. This invention pertains to a compound that has potential applications in treating diseases associated with BTK. The patent includes details on the compound's formula, its stereoisomers, pharmacologically acceptable salts, preparation methods, and pharmaceutical compositions.
Career Highlights
Wang is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a key figure in the industry, contributing to the advancement of therapeutic solutions.
Collaborations
Some of his notable coworkers include Yinsheng Zhang and Hongjiang Xu, who collaborate with him on various projects within the pharmaceutical sector.
Conclusion
Qinglin Wang's innovative work in pharmaceutical chemistry exemplifies the impact of dedicated research on medical advancements. His contributions, particularly in developing BTK inhibitors, highlight the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile